Condition: Pyoderma Gangrenosum · Skin Diseases · Wound Heal · Sponsor: Oregon Health and Science University
A single-arm open-label study assessing short-term (week 6, 16) and long-term (week 32) efficacy of guselkumab in adult participants with pyoderma gangrenosum (PG)
This description comes directly from the study's public registry record.
Alex G Ortega-Loayza, MD, MCR · 503-418-3376 · ortegalo@ohsu.edu
Always discuss trial participation with your own doctor first.
| Ohio State Dermatology | Columbus, Ohio, United States | Recruiting |
| Oregon Health and Science University | Portland, Oregon, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06563323